GILD · 10-Q · 2026Q3 · Full report
Medicare Drug Price Negotiation
GILEAD SCIENCES, INC. · 2026-10-30 · Importance 48 · Surprise 48 · In source text
In October 2026, the Centers for Medicare and Medicaid Services completed setting the Maximum Fair Price for Biktarvy under Medicare. The negotiated price takes effect on January 1, 2028, and management states that it will affect Biktarvy revenue beginning then. The filing does not quantify the expected revenue impact.
Key facts
- In October 2026, CMS completed setting Biktarvy’s Medicare Maximum Fair Price; the new price will affect Biktarvy revenue beginning January 1, 2028. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | committed | — | In October 2026, CMS completed setting Biktarvy’s Medicare Maximum Fair Price; the new price will affect Biktarvy revenue beginning… |